NFASC and chronic inflammatory demyelinating polyradiculoneuropathy: Anti-NF antibodies (ANFAs) have been reported in multiple sclerosis (MS), chronic inflammatory demyelinating neuropathy (CIDP), Guillain–Barré syndrome (GBS), and CCDP [7,8,9,10,11,12].